Search research articles
Contact Us
Filters
Showing results (81-90 of 221) with videos related to
Page
of 23
Sort By:
Annals of the Rheumatic Diseases
|
November 15, 2005
Therapeutic interleukin (IL) 1 blockade normalises increased IL1 beta and decreased tumour necrosis factor alpha and IL10 production in blood mononuclear cells of a patient with CINCA syndrome
M Seitz, R K Kamgang, H U Simon, et al.
Annals of the Rheumatic Diseases
|
September 14, 2004
A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments
M Østensen, L Fuhrer, R Mathieu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 15, 1993
IL-1 beta and IL-6 selectively induce transforming growth factor-beta isoforms in human articular chondrocytes
P M Villiger, A B Kusari, P ten Dijke, et al.
Journal of Clinical Immunology
|
September 1, 1993
Regulation of interleukin-6 (IL-6) expression: evidence for a tissue-specific role of protein kinase C
V Gross, B Zhang, Y Geng, et al.
Swiss Medical Weekly
|
October 24, 2014
Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases
Diana Dan, Rahel Fischer, Sabine Adler, et al.
Swiss Medical Weekly
|
November 10, 2017
Identification of a MAFB mutation in a patient with multicentric carpotarsal osteolysis
Lei Zhuang, Sabine Adler, Daniel Aeberli, et al.
Schweizerische Medizinische Wochenschrift
|
December 29, 2000
[Whipple's disease with normal intestinal histology: rarity or reality?]
R Hirsbrunner-Erni, M Altwegg, P A Diener, et al.
Rheumatology (Oxford, England)
|
February 17, 2010
Patients with diffuse idiopathic skeletal hyperostosis do not have increased peripheral bone mineral density and geometry
Prisca Eser, Harald Bonel, Michael Seitz, et al.
Rheumatology International
|
November 15, 2006
A novel therapeutic option in Cogan diseases? TNF-alpha blockers
M Fricker, A Baumann, F Wermelinger, et al.
The Medical Clinics of North America
|
July 9, 2010
The complex clinical picture of side effects to biologicals
Oliver V Hausmann, Michael Seitz, Peter M Villiger, et al.
Page
of 23
Search research articles
Search
Showing results (81-90 of 221) with videos related to
Sort By:
Page
of 23
Annals of the Rheumatic Diseases
|
November 15, 2005
Therapeutic interleukin (IL) 1 blockade normalises increased IL1 beta and decreased tumour necrosis factor alpha and IL10 production in blood mononuclear cells of a patient with CINCA syndrome
M Seitz, R K Kamgang, H U Simon, et al.
Annals of the Rheumatic Diseases
|
September 14, 2004
A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments
M Østensen, L Fuhrer, R Mathieu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 15, 1993
IL-1 beta and IL-6 selectively induce transforming growth factor-beta isoforms in human articular chondrocytes
P M Villiger, A B Kusari, P ten Dijke, et al.
Journal of Clinical Immunology
|
September 1, 1993
Regulation of interleukin-6 (IL-6) expression: evidence for a tissue-specific role of protein kinase C
V Gross, B Zhang, Y Geng, et al.
Swiss Medical Weekly
|
October 24, 2014
Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases
Diana Dan, Rahel Fischer, Sabine Adler, et al.
Swiss Medical Weekly
|
November 10, 2017
Identification of a MAFB mutation in a patient with multicentric carpotarsal osteolysis
Lei Zhuang, Sabine Adler, Daniel Aeberli, et al.
Schweizerische Medizinische Wochenschrift
|
December 29, 2000
[Whipple's disease with normal intestinal histology: rarity or reality?]
R Hirsbrunner-Erni, M Altwegg, P A Diener, et al.
Rheumatology (Oxford, England)
|
February 17, 2010
Patients with diffuse idiopathic skeletal hyperostosis do not have increased peripheral bone mineral density and geometry
Prisca Eser, Harald Bonel, Michael Seitz, et al.
Rheumatology International
|
November 15, 2006
A novel therapeutic option in Cogan diseases? TNF-alpha blockers
M Fricker, A Baumann, F Wermelinger, et al.
The Medical Clinics of North America
|
July 9, 2010
The complex clinical picture of side effects to biologicals
Oliver V Hausmann, Michael Seitz, Peter M Villiger, et al.
Page
of 23